Daniel Kwame Afosah

Virginia Commonwealth University

$817,893

Attributed

$817,893

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $235.7K · FY2022–25

$250K$187.5K$125K$62.5K$0

'22

'23

'24

'25

Funding mix

By agency

NIH$817,893 · 2

By mechanism

R00$459,117 · 1

K99$358,776 · 1

Top collaborators

No co-investigators on record.

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Other Rising Stars on “Advisory Committees”

Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
Johanna Marizan-Ho · Palantir Technologies, Inc.$9,612,691
Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
Brian Todd Schaneberg · Illinois Institute Of Technology$6,784,113
Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
Christine O'Connell · H. Lee Moffitt Cancer Ctr & Res Inst$5,494,823

Research focus

Advisory CommitteesComplexAnalogAnalytical UltracentrifugationAffinityAdvanced DevelopmentBinding ProteinsBiologicalBiologyBiomacromoleculeBiophysical AnalysisBiophysical TechniquesBiopolymersBindingBlood CirculationBlood PlateletsBone MarrowCareerCareer ChoiceCareer DevelopmentChargeChemical PropertyCoagulation ProcessComputer Studies

Grant awards (4)

Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis$223,435

R00 · FY2025 · HL · contact PI

Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis$235,682

R00 · FY2024 · HL · contact PI

Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis$179,388

K99 · FY2023 · HL · contact PI

Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis$179,388

K99 · FY2022 · HL · contact PI